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Abstract
Background: Soft tissue sarcomas in the head and neck region are rare and often present a
difficult differential diagnosis. The aim of our presentation is to point out the complexity of the
diagnosis, treatment and follow up.
Case presentation: An eighty-seven year old female patient was referred to our unit with a fast
growing brownish lump on the face. Four months beforehand, a benign fibrous histiocytoma (BFH)
had been removed from the same location by excision biopsy with wide tumour-free resection
margins. Excision biopsy of the recurrent lesion revealed a malignant fibrous histiocytoma (MFH).
Radical tumour resection was completed by extended parotidectomy and neck dissection; the skin
defect was covered by a regional bi-lobed flap. No adjuvant radio- or chemotherapy was
administered. Full functional and cosmetic recovery was achieved; follow-up has been uneventful
more than two years postoperatively.
Discussion: Malignant transformation of BFH is extremely rare and if so, extended radical surgery
may give a fair chance for a favourable outcome even in patients with advanced age.
Background
Soft tissue tumours in the head and neck region some-
times display borderline pathological features regarding
benign or malignant behaviour. Despite similar histolog-
ical patterns the clinical outcome is often different and
difficult to predict.
Malignant fibrous histiocytoma [MFH] is a primitive,
often pleomorphic sarcoma consisting of partly fibrob-
last-like, partly histiocyte-like cells. It has been classified
as a distinct histopathological entity since the nineteen-
sixties [1]. Nowadays, it is one of the most common soft
tissue sarcomas of late adult life, with a male predomi-
nance since all neoplasms of mesodermal origin previ-
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ously regarded as sarcomas of uncertain origin are now
included in the category of MFH [2]
Changing of the histological picture during progression of
the disease and transformation of borderline-benign
lesions to malignant phenotype has been described.
Reported incidence of malignant transformation lies
around 1% [3].
Benign fibrous histiocytoma [BFH] is the most common
benign neoplasm in practically all localizations affecting
the epidermis. The proliferative, atypical or borderline
type is a cell-dense variant mostly growing faster and
greater in size, with characteristically frequent local recur-
rences, reported incidence lying at 3–5%. Both BFH and
its borderline variant are known not to give either haema-
togenous or loco-regional metastases to lymph-nodes [4].
The aim of our presentation is to point out the complexity
of the diagnosis, treatment and follow up of patients with
soft tissue tumours of borderline character.
Case presentation
An eighty-seven year old woman was referred to our
department because of a fast-growing, dark-brownish,
indurated skin nodule sized 3 cm in diameter, which infil-
trated the skin and the deeper soft tissue layers of the face
(Fig 1.) Four months beforehand, a benign cutaneous his-
tiocytoma (BFH) had been removed from the same loca-
tion by excision biopsy (Fig. 2a–d), which had been a
painless, slow-growing, brownish lump not exceeding 1
cm in diameter clinically. Surgical margins had been dis-
ease-free.
Excision biopsy of the current lesion revealed an infiltra-
tive, well-vascularised mesenchymal neoplasm contain-
ing pleomorphic tumour cells, increased mitotic count
with some atypical mitoses, and myxoid stroma rich in
collagen fibres. Immunohistochemistry was strongly pos-
itive for vimentin, and negative for cytokeratin, smooth-
muscle actin, desmin, S-100 and melanoma-specific anti-
gen. The MIB1 positive proliferative fraction was 50%
(Fig. 3a–d). The histological diagnosis of a "myxoid-type
malignant fibrous histiocytoma (MFH)" with tumour-free
surgical margins up to 3 cm was made [pT1a, pN0 (26/0),
pMx, R0]. Histological re-evaluation of the primary
tumour by an independent pathologist confirmed the
original diagnosis of benign fibrous histiocytoma with
ulceration, inflammation and increased cellularity ("irri-
tated BFH").
Clinical staging investigations of the current malignancy
[chest X-ray, MRI-scan of the neck and skull, abdominal
and neck ultrasound, bone scintigraphy] showed superfi-
cial infiltration of the cutis and subcutis. Neither infiltra-
tion of the Masseter nor metastases in the regional lymph
nodes or elsewhere were found. Radical excision of the
tumour was completed by parotidectomy and modified
neck dissection, which resulted in a cosmetic defect of the
right face that was immediately corrected by a local bi-
lobed flap (Fig. 4). No postoperative radio- or chemother-
apy was applied. Two years postoperatively, the patient
was alive and well with full cosmetic and functional recov-
ery. (Fig. 5) She died after a heart attack three years after
surgery without any signs of tumour recurrence or metas-
tasis. Autopsy was not carried out.
Discussion
Benign fibrous histiocytomas (BFH) are frequently found
in sun-exposed skin of the extremities and of the head and
neck. They are among the most common soft tissue
lesions of the skin [1]. Their biological nature, in particu-
lar whether they are neoplastic or reactive, has long been
disputed. Recent studies have found cytogenetic evidence
of clonal chromosomal abnormalities in a part of lesions,
which support their neoplastic origin [5]. In addition to
the common histological pattern, a number of variants are
recognized, some of which can be confused with sarcoma.
Of the cellular and atypical types, about 20% are localised
in the head and neck region, they usually grow faster and
are greater in size than the other subtypes, and tend to
recur locally (up to 26%) [4]. Reported incidence of
malignant transformation is around 1% [3].
In contrast, malignant fibrous histiocytoma (MFH) is a
sarcoma with both fibroblastic and histiocytic features. It
has been classified as a distinct histopathological entity
since the nineteen-sixties [1]. Nowadays, it is one of the
most commonly diagnosed sarcomas of late adulthood,
Preoperative view of the lesion on the right cheek: a smooth,  firm nodule with wide erythematous border Figure 1
Preoperative view of the lesion on the right cheek: a smooth, 
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(A-D). Histopathological and immunohistochemical findings of the recurrent lesion diagnosed as malignant fibrous histiocytoma  of myxoid type Figure 3
(A-D). Histopathological and immunohistochemical findings of the recurrent lesion diagnosed as malignant fibrous histiocytoma 
of myxoid type: (A) Heterogeneous fibroblastic spindle cells, histiocytic, inflammatory and pleomorphic giant cells are scattered 
throughout the tumour mass embedded in myxoid stroma containing plentiful collagen fibres. (H&E, 200×). (B) Negative immu-
nohistochemical reaction for cytokeratins [pan-anti-cytokeratin antibody; KL-1 (Ventana, Germany)], (C) Strong positive reac-
tion with the MIB1 antibody showing a high proliferative activity of the tumor, MIB-1 labelling index: 50%(100×), (D) Strongly 
positive immunohistochemical reaction for vimentin in the vast majority of tumour cells (400×)
(A-D). Histopathological findings of the excision biopsy specimen from the primary benign fibrous histiocytoma Figure 2
(A-D). Histopathological findings of the excision biopsy specimen from the primary benign fibrous histiocytoma: (A) The over-
lying epidermis is ulcerated and mildly acanthotic (H&E, 40×). (B) Subcutaneous cellular aggregation of spindle-shaped, fibrob-
last-like and histiocytic cells poorly demarcated from the surrounding tissues (H&E, 100×) (C) The spindled cells are arranged 
in interlacing fascicles forming a storiform pattern (H&E, 200×). (D) They are accompanied by varying numbers of inflammatory 
cells, foam cells and siderophages as well as proliferating capillaries (H&E, 200×)Head & Face Medicine 2007, 3:36 http://www.head-face-med.com/content/3/1/36
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since all neoplasms previously regarded as sarcomas of
uncertain origin are now included in this category [2].
MFH typically arises in the soft tissues of the extremities
and retroperitoneum, the head and neck region is seldom
involved. In superficial sites such as the skin, MFH may
behave in a benign fashion despite high-grade looking
and fast growing tumour cells.
The primary treatment of MFH consists of radical excision
with wide safety margins and dissection of the loco-
regional lymph nodes [6]. Post- or sometimes even preop-
erative radio- or chemotherapy may be an adjuvant
option of treatment, however their indications and effi-
cacy remain controversial [2,6]. In the present case, we
have disregarded adjuvant oncological treatment because
of the age of the patient and the lack of clear-cut evidence
for indication.
In conclusion, predicting biological behaviour on the
base of cellular features in cutaneous fibrohistiocytic
tumours is sometimes very difficult. It is well illustrated by
the present case, which showed malignant transformation
in recurrence despite the bland histopathological appear-
ance of the primary lesion. It is therefore mandatory that
patients with such lesions are closely monitored postoper-
atively, so as to be able to act promptly in case of local
recurrences. Patients' management requires close collabo-
ration between dermatologists, maxillo-facial surgeons,
radiologists and pathologists, which may result in suffi-
cient clinical outcome.
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Intraoperative view after conservative neck dissection and  prior to tumour removal, parotidectomy and placing of the  local bi-lobed flap Figure 4
Intraoperative view after conservative neck dissection and 
prior to tumour removal, parotidectomy and placing of the 
local bi-lobed flap. The safety margin is well marked around 
the tumour and the preparation of the flap is completed.
Six months postoperatively with full cosmetic and functional  recovery Figure 5
Six months postoperatively with full cosmetic and functional 
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